Skip to content
value.today

Dicerna Pharmaceuticals

DRNAUnlisted company
$1.7 Blast known market cap, Jan 2021 — no current value
Compare
World rank
—
no current market cap
Revenue
$164 M
Dec-2020 ending year
value.today research
Net income
$-113 M
-68.9% margin
value.today research
Employees
78
As on 2020
value.today research

Dicerna Pharmaceuticals in brief

Dicerna Pharmaceuticals is an unlisted company in the Biotechnology industry, based in Massachusetts, USA. In the year to Dec 2020 it had sales of $164 M and a net loss of $113 M. It employs about 78 people.

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

About Dicerna Pharmaceuticals

Biotechnology company with headquarters is in Massachusetts, USA.

More about Dicerna Pharmaceuticals

Acquisitions and changes
No longer listed: ticker DRNA is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$446 M$893 M$1.3 B$1.8 B20202021

World rank over time

▲ up 11 places since 2020
2020-01-01: #6089#6,08920202021-01-01: #6078#6,0782021

Rank in USA: #1,664 (Jan 2020) · #1,688 (Jan 2021)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-68.9%
Operating margin
—
Return on equity
—
Liabilities / assets
—
Revenue per employee
$2.1 M
Profit per employee
$-1.4 M

Annual results

Revenue
$164 M
Operating income
—
Net income
$-113 M

Dec-2020 ending year

Where Dicerna Pharmaceuticals operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Dicerna Pharmaceuticals: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Dicerna Pharmaceuticals: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters—

H-1B hiring at Dicerna Pharmaceuticals#

8 labor condition applications certified in fiscal 2025 for 8 positions, at a median wage of $115 K a year.

Certified, FY2025
8
#983 among companies on value.today
Worker positions
8
Median wage offered
$115 K
a year, full-time
Applications filed
8
Dicerna Pharmaceuticals: most frequent H-1B job titles in fiscal 2025
Job titlePositionsMedian wage offered
ASSOC COMPUTATIONAL BIOLOGISTBioinformatics Scientists1$109 K
ASSOC SCIENTIST II - DISCOVERY RESEARCHBiochemists and Biophysicists1$108 K
Research Associate, RNAi DiscoveryBiologists1$75 K
SCIENTIST I - CHEM DEVChemists1$130 K
SCIENTIST II “ RNA GENE THERAPYMolecular and Cellular Biologists1$150 K
Scientist I - Translational BiologyBiologists1$120 K
Scientist I, Medicinal ChemistryChemists1$130 K
Senior Research AssociateChemists1$85 K

Where: Lexington, MA 7 · Boulder, CO 1

Dicerna Pharmaceuticals: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202588$115 K8
FY20241111$139 K11
FY202366$106 K6
FY202288$88 K8
FY202177$108 K7
FY202044$94 K4

How Dicerna Pharmaceuticals compares in Biotechnology

  • Revenue$164 M · higher than 74% of 648
  • Net margin-68.9% · higher than 48% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Dicerna Pharmaceuticals🇺🇸$1.7 B—-68.9%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 1, 2021 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Employees:
As on 2020
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Dicerna Pharmaceuticals? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Dicerna Pharmaceuticals's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Dicerna Pharmaceuticals? Suggest a correction